Carotid stent investigational device exemption applications sought by FDA.
This article was originally published in The Gray Sheet
CAROTID STENT INVESTIGATIONAL DEVICE EXEMPTION SUBMISSIONS SOUGHT BY FDA to ensure that safety and efficacy information is gathered on the off-label use of stents in the carotid artery, the agency says. The agency is in the process of drafting a suggested clinical protocol for IDE trials.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.